Maharaj Zia, Pietrzak Jurek Rafal Tomasz, Sikhauli Nkhodiseni, van de Jagt Dick, Mokete Lipalo
Charlotte Maxeke Johannesburg Academic Hospital, Jubilee Road, Parktown, Johannesburg, Gauteng 2196, South Africa.
SICOT J. 2020;6:3. doi: 10.1051/sicotj/2019042. Epub 2020 Jan 22.
The aim was to assess the seroprevalence of Human Immunodeficiency Virus (HIV) in non-haemophilic patients undergoing primary Total Joint Arthroplasty (TJA) at an academic hospital in South Africa.
A retrospective review of all Total Hip Arthroplasty (THA) and Total Knee Arthroplasty (TKA) patients from January 2017 to December 2018 was conducted. All patients awaiting TJA were offered HIV screening and their demographic data were recorded. Consenting patients were tested or the refusal of testing was documented. The CD4+ T-cell count (CD4+) and viral load (VL) was measured for all HIV-positive patients and newly diagnosed patients were initiated on Highly Active Antiretroviral Treatment (HAART).
We included 1007 patients in the study. The TJA population HIV seroprevalence was 10.7% (n = 108). The seroprevalence for THA was 14.9% (n = 78) and that for TKA was 6.2% (n = 30). There were 93 patients (9.2%) who refused screening. There were 12 (15.4%) and 3 patients (10%) that were newly diagnosed in the THA and TKA seropositive populations, respectively. The average CD4+ for THA and TKA was 569 cells/mm (105-1320) and 691 cells/mm (98-1406), respectively. The VL was undetectable in 75.9% (n = 82) of HIV-positive patients. Overall 12 HIV-positive patients (11.12%) had CD4+ <200 cells/mm, 8 of these patients (66%) were newly diagnosed. The average age of the seropositive population was 58 ± 6.5 years and 66 ± 8.5 years for THA and TKA, respectively (p = 0.03). Femoral head osteonecrosis was the underlying pathology for 65.38% (n = 51) of seropositive patients for THA.
The seroprevalence of HIV in patients undergoing THA in our South African institution is greater than the seroprevalence in the general population. The seroprevalence of HIV in THA is significantly greater than that in TKA. This may reflect the association between HIV, HAART and hip joint degeneration. Our findings draw attention to the significant burden HIV has on TJA.
评估南非一家学术医院接受初次全关节置换术(TJA)的非血友病患者中人类免疫缺陷病毒(HIV)的血清流行率。
对2017年1月至2018年12月期间所有接受全髋关节置换术(THA)和全膝关节置换术(TKA)的患者进行回顾性研究。为所有等待TJA的患者提供HIV筛查,并记录他们的人口统计学数据。对同意的患者进行检测,或记录拒绝检测的情况。对所有HIV阳性患者测量CD4 + T细胞计数(CD4 +)和病毒载量(VL),并为新诊断的患者开始高效抗逆转录病毒治疗(HAART)。
我们纳入了1007例患者进行研究。TJA人群的HIV血清流行率为10.7%(n = 108)。THA的血清流行率为14.9%(n = 78),TKA的血清流行率为6.2%(n = 30)。有93例患者(9.2%)拒绝筛查。在THA和TKA血清阳性人群中分别有12例(15.4%)和3例(10%)为新诊断患者。THA和TKA的平均CD4 +分别为569个细胞/mm(105 - 1320)和691个细胞/mm(98 - 1406)。75.9%(n = 82)的HIV阳性患者病毒载量检测不到。总体而言,12例HIV阳性患者(11.12%)的CD4 + <200个细胞/mm,其中8例(66%)为新诊断患者。血清阳性人群的平均年龄,THA组为58±6.5岁,TKA组为66±8.5岁(p = 0.03)。股骨头坏死是THA血清阳性患者中65.38%(n = 51)的潜在病理情况。
在我们南非的机构中,接受THA的患者中HIV的血清流行率高于一般人群。THA中HIV的血清流行率显著高于TKA。这可能反映了HIV、HAART与髋关节退变之间的关联。我们的研究结果提醒人们注意HIV对TJA造成的重大负担。